ConCallIQ
Go Pro
FCL Diversified 01 May 2026

Fineotex Chemical Limited — Q4 FY26

Fineotex Chemical delivered a stellar Q4 FY26, with revenue surging 162% YoY to ₹314 crore and PAT jumping 118% to ₹44 crore, driven by the December 2025 acquisition of Crude Chem Technologies (CCT) and strong organic textile chemical growth.

bullish high
Compare with...
Revenue ₹314 Cr +162%
EBITDA
PAT ₹44 Cr +118%
EBITDA Margin 14%
Duration 58 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Fineotex Chemical delivered a stellar Q4 FY26, with revenue surging 162% YoY to ₹314 crore and PAT jumping 118% to ₹44 crore, driven by the December 2025 acquisition of Crude Chem Technologies (CCT) and strong organic textile chemical growth. The US oilfield chemicals business contributed ~₹165 crore in Q4, with management confident of scaling to $200 million revenue by FY28 (revised from 2030). Consolidated EBITDA margin stood at 14%, with a target of 18-20% in the near term. The company is doubling CCT's manufacturing capacity and has already deployed $7 million in capex. Textile volumes grew 15% YoY, supported by improving export demand. Risks include working capital pressure (79 days) and global logistics disruptions, though management views these as manageable. The strong balance sheet (₹300+ crore cash) supports further inorganic opportunities.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Working capital pressure from inventory buildup

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

CCT Revenue Contribution ₹165 Cr
+100% QoQ (approx)

Crude Chem contributed ~₹165 crore in Q4 FY26, forming the bulk of the incremental revenue.

International Revenue Share 70%
+20pp YoY (approx)

International revenue share rose to 70% in Q4 FY26 from ~50% in Q4 FY25, reflecting global diversification.

ROIC 31%
flat YoY

Return on invested capital remained healthy at 31%, indicating efficient capital allocation.

Textile Volume Growth 15%
+15% YoY

Textile specialty chemical volumes grew 15% YoY in Q4, driven by improving export demand.

What Changed vs Last Quarter

Comparing Q4 FY26 vs Q3 FY26
4 new guidance4 dropped4 new risk4 risk resolved
NEW
CCT revenue target of $200 million by FY28

Management revised the CCT revenue target from 2030 to FY28, with Q4 FY26 as the baseline run-rate of ~$90-100 million.

NEW
Consolidated EBITDA margin target of 18-20%

Management expects blended EBITDA margins to improve to 18-20% in the near term, possibly within FY27.

NEW
Doubling CCT manufacturing capacity

CCT's manufacturing capacity is being doubled with $7 million capex already deployed; new machines being installed.

NEW
Further 25% stake acquisition in CCT by January 2028

Agreement to acquire an additional 25% stake from founders by January 2028, increasing ownership to ~79-80%.

DROPPED
FY27 revenue target of ₹1,000 crore+

Management expects consolidated revenue to exceed ₹1,000 crore in the next financial year, driven by CCT full-year contribution and textile recovery.

DROPPED
Oil & gas to contribute 45-50% of revenue

Oil & gas segment (including CCT) is expected to account for 45-50% of total revenue going forward.

DROPPED
CCT margins to improve to double digits

CCT's EBITDA margins, historically around 7-8%, are expected to improve to double digits due to capital infusion and better procurement.

DROPPED
Capex of ₹70-80 crore over 1.5-2 years

Capital expenditure for CCT expansion and other projects is expected to be around ₹70-80 crore (less than $10 million) over the next 1.5-2 years.

NEW RISK
Working capital pressure from inventory buildup

Working capital cycle increased to 79 days (85 days for CCT) due to global logistics disruptions and raw material shortages, which could strain cash flows.

NEW RISK
Global logistics and raw material cost volatility

Management acknowledged container shortages and freight cost increases, which may impact margins if not fully passed through.

NEW RISK
Integration and execution risk in CCT scale-up

Rapid capacity expansion and technology transfer to CCT may face operational hiccups, though management is confident.

NEW RISK
Dependence on US oilfield market conditions

CCT's growth is tied to US oil and gas activity; any downturn in drilling or regulatory changes could impact demand.

RISK GONE
CCT integration and margin improvement timeline

CCT was consolidated for only 15 days in Q3; achieving double-digit margins may take longer than expected due to integration complexities.

RISK GONE
Textile margin pressure from discount rollback

Management provided discounts to textile customers during the tariff uncertainty and plans to roll them back from March 2026, which could impact customer retention.

RISK GONE
Domestic revenue stagnation

Domestic revenue remained flat YoY at ~₹95.6 crore, indicating limited organic growth in the home market despite new capacity.

RISK GONE
Dependence on US trade policy for textile recovery

Textile recovery hinges on favorable US tariff resolution; any reversal or delay could impact expected order book improvement.

Fast read

Guidance and risk preview

Top guidance CCT revenue target of $200 million by FY28

Management revised the CCT revenue target from 2030 to FY28, with Q4 FY26 as the baseline run-rate of ~$90-100 million.

Top risk Working capital pressure from inventory buildup

Working capital cycle increased to 79 days (85 days for CCT) due to global logistics disruptions and raw material shortages, which could strain cas...

View Risks →